A role of influenza virus exposure history in determining pandemic susceptibility and CD8+ T cell responses

Journal of Virology

Volumn 90, Issue 15, 2016, Pages 6936-6947

  Quiñones Parra, Sergio M ^a   Bridie Clemens, E ^a   Wang, Zhongfang ^a   Croom, Hayley A ^a   Kedzierski, Lukasz ^a   McVernon, Jodie ^b   Vijaykrishna, Dhanasekaran ^c   Kedzierskaa, Katherine ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A ANTIGEN; HLA B ANTIGEN; INFLUENZA VACCINE; NUCLEOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUSTRALIAN; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CRYOPRESERVATION; CYTOTOXIC T LYMPHOCYTE; DISEASE PREDISPOSITION; GENOTYPE; GROUPS BY AGE; HUMAN; HUMORAL IMMUNITY; IMMUNE EVASION; INFLUENZA; INFLUENZA A (H2N2); INFLUENZA VIRUS; MEMORY T LYMPHOCYTE; MORBIDITY; MOUSE; NONHUMAN; PANDEMIC INFLUENZA; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYLOGENY; PRIORITY JOURNAL; ADULT; ANIMAL; B LYMPHOCYTE; CHILD; CROSS PROTECTION; FEMALE; IMMUNOLOGY; MOLECULAR EVOLUTION; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRUS INFECTION; PANDEMIC; VIROLOGY;

ADULT; ANIMALS; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CROSS PROTECTION; EPITOPES, T-LYMPHOCYTE; EVOLUTION, MOLECULAR; FEMALE; HUMANS; INFLUENZA, HUMAN; MICE; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; PANDEMICS; PHYLOGENY; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84982816382     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00349-16     Document Type: Article

References (77)

1. World Health Organization. 2011. Global health observatory data repository. World Health Organization, Geneva, Switzerland. http://apps.who.int/ghodata/?vid10012.
2. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB. 2007. The annual impact of seasonal influenza in the United States: measuring disease burden and costs. Vaccine 25:5086-5096. http://dx.doi.org/10.1016/j.vaccine.2007.03.046.
3. Uyeki TM, Cox NJ. 2013. Global concerns regarding novel influenza A (H7N9) virus infections. N Engl J Med 368:1862-1864. http://dx.doi.org/10.1056/NEJMp1304661.
4. Kilbourne ED, Smith C, Brett I, Pokorny BA, Johansson B, Cox N. 2002. The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic. Proc Natl Acad Sci USA 99:10748-10752. http://dx.doi.org/10.1073/pnas.162366899.
5. Rimmelzwaan GF, Kreijtz JH, Bodewes R, Fouchier RA, Osterhaus AD. 2009. Influenza virus CTL epitopes, remarkably conserved and remarkably variable. Vaccine 27:6363-6365. http://dx.doi.org/10.1016/j.vaccine.2009.01.016.
6. Assarsson E, Bui HH, Sidney J, Zhang Q, Glenn J, Oseroff C, Mbawuike IN, Alexander J, Newman MJ, Grey H, Sette A. 2008. Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans. J Virol 82:12241-12251. http://dx.doi.org/10.1128/JVI.01563-08.
7. + T lymphocytes. J Immunol 172:2453-2460. http://dx.doi.org/10.4049/jimmunol.172.4.2453.
8. Lee LY, Ha do, Simmons LAC, de Jong MD, Chau NV, Schumacher R, Peng YC, McMichael AJ, Farrar JJ, Smith GL, Townsend AR, Askonas BA, Rowland-Jones S, Dong T. 2008. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 118:3478-3490. http://dx.doi.org/10.1172/JCI32460.
9. Kreijtz JH, de Mutsert G, van Baalen CA, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. 2008. Cross-recognition of avian H5N1 influenza virus by human cytotoxic T lymphocyte populations directed to human influenza A virus. J Virol 82:5161-5166. http://dx.doi.org/10.1128/JVI.02694-07.
10. van de Sandt CE, Kreijtz JH, de Mutsert G, Geelhoed-Mieras MM, Hillaire ML, Vogelzang-van Trierum SE, Osterhaus AD, Fouchier RA, Rimmelzwaan GF. 2014. Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus. J Virol 88:1684-1693. http://dx.doi.org/10.1128/JVI.02843-13.
11. Yap KL, Ada GL, McKenzie IFC. 1978. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 273: 238-239. http://dx.doi.org/10.1038/273238a0.
12. Bender BS, Croghan T, Zhang L, Small PA, Jr. 1992. Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med 175:1143-1145. http://dx.doi.org/10.1084/jem.175.4.1143.
13. Epstein SL, Lo CY, Misplon JA, Bennink JR. 1998. Mechanism of protective immunity against influenza virus infection in mice without antibodies. J Immunol 160:322-327.
14. McMichael AJ, Gotch FM, Noble GR, Beare PA. 1983. Cytotoxic T-cell immunity to influenza. N Engl J Med 309:13-17. http://dx.doi.org/10.1056/NEJM198307073090103.
15. Sridhar S, Begom S, Bermingham A, Hoschler K, Adamson W, Carman W, Bean T, Barclay W, Deeks JJ, Lalvani A. 2013. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med 19:1305-1312. http://dx.doi.org/10.1038/nm.3350.
16. + T cells. Nat Commun 6:6833. http://dx.doi.org/10.1038/ncomms7833.
17. Hayward AC, Wang L, Goonetilleke N, Fragaszy EB, Bermingham A, Copas A, Dukes O, Millett ER, Nazareth I, Nguyen-Van-Tam JS, Watson JM, Zambon M, Johnson AM, McMichael AJ, Flu Watch G. 2015. Natural T cell-mediated protection against seasonal and pandemic influenza: results of the Flu Watch Cohort Study. Am J Respir Crit Care Med 191:1422-1431. http://dx.doi.org/10.1164/rccm.201411-1988OC.
18. + T cells is determined by extraepitopic amino acid residues. J Virol 90:1009-1022. http://dx.doi.org/10.1128/JVI.02439-15.
19. Epstein SL. 2006. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis 193:49-53. http://dx.doi.org/10.1086/498980.
20. Rasmussen AF, Jr, Stokes JC, Smadel JE. 1948. The Army experience with influenza, 1946-1947: laboratory aspects. Am J Hyg 47:142-149.
21. Isaacs A, Gledhill AW, Andrewes CH. 1952. Influenza A viruses; laboratory studies, with special reference to European outbreak of 1950-1. Bull World Health Organ 6:287-315.
22. Nelson MI, Viboud C, Simonsen L, Bennett RT, Griesemer SB, St George K, Taylor J, Spiro DJ, Sengamalay NA, Ghedin E, Taubenberger JK, Holmes EC. 2008. Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog 4:e1000012. http://dx.doi.org/10.1371/journal.ppat.1000012.
23. Joseph U, Linster M, Suzuki Y, Krauss S, Halpin RA, Vijaykrishna D, Fabrizio TP, Bestebroer TM, Maurer-Stroh S, Webby RJ, Wentworth DE, Fouchier RA, Bahl J. 2015. Adaptation of pandemic H2N2 influenza A viruses in humans. J Virol 89:2442-2447. http://dx.doi.org/10.1128/JVI.02590-14.
24. Webster RG. 1997. Predictions for future human influenza pandemics. J Infect Dis 176(Suppl 1):S14-S19. http://dx.doi.org/10.1086/514168.
25. Schafer J, Khristova ML, Busse TL, Sinnecker R, Kharitonenkov IG, Schrader C, Suss J, Bucher D. 1992. Analysis of internal proteins of influenza A (H2N2) viruses isolated from birds in East Germany in 1983. Acta Virol 36:113-120.
26. Makarova NV, Kaverin NV, Krauss S, Senne D, Webster RG. 1999. Transmission of Eurasian avian H2 influenza virus to shorebirds in North America. J Gen Virol 80(Pt 12):3167-3171. http://dx.doi.org/10.1099/0022-1317-80-12-3167.
27. Jones JC, Baranovich T, Marathe BM, Danner AF, Seiler JP, Franks J, Govorkova EA, Krauss S, Webster RG. 2014. Risk assessment of H2N2 influenza viruses from the avian reservoir. J Virol 88:1175-1188. http://dx.doi.org/10.1128/JVI.02526-13.
28. Quinones-Parra S, Loh L, Brown LE, Kedzierska K, Valkenburg SA. 2014. Universal immunity to influenza must outwit immune evasion. Front Microbiol 5:285. http://dx.doi.org/10.3389/fmicb.2014.00285.
29. + T-cell immunity to the H7N9 influenza A virus varies across ethnicities. Proc Natl Acad Sci USA 111:1049-1054. http://dx.doi.org/10.1073/pnas.1322229111.
30. + T cells reveals a unique TCR signature in a clinical setting. J Immunol 192:5039-5049. http://dx.doi.org/10.4049/jimmunol.1303147.
31. Wang GC, Dash P, McCullers JA, Doherty PC, Thomas PG. 2012. T cell receptor [H9251][H9252] diversity inversely correlates with pathogen-specific antibody levels in human cytomegalovirus infection. Sci Transl Med 4:128ra142. http://dx.doi.org/10.1126/scitranslmed.3003647.
32. Kitamura D, Roes J, Kuhn R, Rajewsky K. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350:423-426. http://dx.doi.org/10.1038/350423a0.
33. + T cells during infection with influenza virus due to selective expression of IFITM3. Nat Immunol 14:238-245. http://dx.doi.org/10.1038/ni.2525.
34. + T-cell responses to influenza A virus in HLA-A2 individuals. Proc Natl Acad Sci USA 108:9178-9183. http://dx.doi.org/10.1073/pnas.1105624108.
35. Guan Y, Vijaykrishna D, Bahl J, Zhu H, Wang J, Smith GJ. 2010. The emergence of pandemic influenza viruses. Protein Cell 1:9-13. http://dx.doi.org/10.1007/s13238-010-0008-z.
36. + T-cell responses. Immunol Cell Biol 91:184-194. http://dx.doi.org/10.1038/icb.2012.78.
37. Smith GJ, Bahl J, Vijaykrishna D, Zhang J, Poon LL, Chen H, Webster RG, Peiris JS, Guan Y. 2009. Dating the emergence of pandemic influenza viruses. Proc Natl Acad Sci USA 106:11709-11712. http://dx.doi.org/10.1073/pnas.0904991106.
38. Carlson JM, Le AQ, Shahid A, Brumme ZL. 2015. HIV-1 adaptation to HLA: a window into virus-host immune interactions. Trends Microbiol 23:212-224. http://dx.doi.org/10.1016/j.tim.2014.12.008.
39. Voeten JT, Bestebroer TM, Nieuwkoop NJ, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. 2000. Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes. J Virol 74:6800-6807. http://dx.doi.org/10.1128/JVI.74.15.6800-6807.2000.
40. Boon AC, de Mutsert G, Graus YM, Fouchier RA, Sintnicolaas K, Osterhaus AD, Rimmelzwaan GF. 2002. Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. J Virol 76:2567-2572. http://dx.doi.org/10.1128/jvi.76.5.2567-2572.2002.
41. + T-cell clones. J Gen Virol 88:530-535. http://dx.doi.org/10.1099/vir.0.82120-0.
42. Rimmelzwaan GF, Boon AC, Voeten JT, Berkhoff EG, Fouchier RA, Osterhaus AD. 2004. Sequence variation in the influenza A virus nucleo-protein associated with escape from cytotoxic T lymphocytes. Virus Res 103:97-100. http://dx.doi.org/10.1016/j.virusres.2004.02.020.
43. + T-cell epitopes of influenza virus nucleoprotein revealed by a comparative analysis of human and swine viral lineages. J Virol 89:11275-11283. http://dx.doi.org/10.1128/JVI.01571-15.
44. + T cell antigenic peptides. Nat Commun 4:2663. http://dx.doi.org/10.1038/ncomms3663.
45. National Center for Biotechnology Information. 2016. dbMHC: diversity anthropology component. National Center for Biotechnology Information, Bethesda, MD. http://www.ncbi.nlm.nih.gov/projects/gv/mhc/main.fcgi?cmdinit.
46. Bird NL, Olson MR, Hurt AC, Oshansky CM, Oh DY, Reading PC, Chua BY, Sun Y, Tang L, Handel A, Jackson DC, Turner SJ, Thomas PG, Kedzierska K. 2015. Oseltamivir prophylaxis reduces inflammation and facilitates establishment of cross-strain protective T cell memory to influenza viruses. PLoS One 10:e0129768. http://dx.doi.org/10.1371/journal.pone.0129768.
47. Iijima N, Iwasaki A. 2014. T cell memory. A local macrophage chemokine network sustains protective tissue-resident memory CD4 T cells. Science 346:93-98. http://dx.doi.org/10.1126/science.1257530.
48. + T cells trigger a state of tissue-wide pathogen alert. Science 346:101-105. http://dx.doi.org/10.1126/science.1254803.
49. Schenkel JM, Fraser KA, Beura LK, Pauken KE, Vezys V, Masopust D. 2014. T cell memory: resident memory CD8 T cells trigger protective innate and adaptive immune responses. Science 346:98-101. http://dx.doi.org/10.1126/science.1254536.
50. Wu T, Hu Y, Lee YT, Bouchard KR, Benechet A, Khanna K, Cauley LS. 2014. Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection. J Leukoc Biol 95:215-224. http://dx.doi.org/10.1189/jlb.0313180.
51. + T(RM) cells providing global skin immunity. Nature 483:227-231. http://dx.doi.org/10.1038/nature10851.
52. + tissue-resident memory T cells of skin. Nat Immunol 14:1294-1301. http://dx.doi.org/10.1038/ni.2744.
53. + T cells responding to infection. Nat Immunol 16:406-414. http://dx.doi.org/10.1038/ni.3108.
54. Park CO, Kupper TS. 2015. The emerging role of resident memory T cells in protective immunity and inflammatory disease. Nat Med 21:688-697. http://dx.doi.org/10.1038/nm.3883.
55. Pircher H, Moskophidis D, Rohrer U, Burki K, Hengartner H, Zinkernagel R. 1990. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346:629-633. http://dx.doi.org/10.1038/346629a0.
56. Moore C, John M, James I, Christiansen F, Witt C, Mallal S. 2002. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296:1439-1443. http://dx.doi.org/10.1126/science.1069660.
57. Fernandez C, Stratov I, De Rose R, Walsh K, Dale C, Smith M, Agy M, Hu S, Krebs K, Watkins D, O'Connor D, Davenport M, Kent S. 2005. Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost. J Virol 79: 5721-5731. http://dx.doi.org/10.1128/JVI.79.9.5721-5731.2005.
58. Gog J, Rimmelzwaan G, Osterhaus A, Grenfell B. 2003. Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A. Proc Natl Acad Sci USA 100:11143-11147. http://dx.doi.org/10.1073/pnas.1830296100.
59. + T cell epitope in influenza A virus matrix protein 1. J Virol 86:10258-10260. http://dx.doi.org/10.1128/JVI.00894-12.
60. Logan WP, Mac KD. 1951. Development of influenza epidemics. Lancet i:264-265.
61. Viboud C, Tam T, Fleming D, Miller MA, Simonsen L. 2006. 1951 influenza epidemic, England and Wales, Canada, and the United States. Emerg Infect Dis 12:661-668. http://dx.doi.org/10.3201/eid1204.050695.
62. Glezen WP. 1996. Emerging infections: pandemic influenza. Epidemiol Rev 18:64-76. http://dx.doi.org/10.1093/oxfordjournals.epirev.a017917.
63. Viboud C, Grais RF, Lafont BA, Miller MA, Simonsen L. 2005. Multinational impact of the 1968 Hong Kong influenza pandemic: evidence for a smoldering pandemic. J Infect Dis 192:233-248. http://dx.doi.org/10.1086/431150.
64. Reichert TA, Christensen RA. 2005. It's not about smoldering or neuraminidase: there were 2 variants of the A(H3N2) pandemic virus differing in internal genes. J Infect Dis 192:1858-1862. http://dx.doi.org/10.1086/497153.
65. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, Brammer TL, Cox NJ, Tumpey TM, Katz JM. 2009. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361:1945-1952. http://dx.doi.org/10.1056/NEJMoa0906453.
66. + T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc Natl Acad Sci USA 107:12599-12604. http://dx.doi.org/10.1073/pnas.1007270107.
67. Li Y, Myers JL, Bostick DL, Sullivan CB, Madara J, Linderman SL, Liu Q, Carter DM, Wrammert J, Esposito S, Principi N, Plotkin JB, Ross TM, Ahmed R, Wilson PC, Hensley SE. 2013. Immune history shapes specificity of pandemic H1N1 influenza antibody responses. J Exp Med 210:1493-1500. http://dx.doi.org/10.1084/jem.20130212.
68. Poehling KA, Edwards KM, Weinberg GA, Szilagyi P, Staat MA, Iwane MK, Bridges CB, Grijalva CG, Zhu Y, Bernstein DI, Herrera G, Erdman D, Hall CB, Seither R, Griffin MR. 2006. The underrecognized burden of influenza in young children. N Engl J Med 355:31-40. http://dx.doi.org/10.1056/NEJMoa054869.
69. + T cell responses in neonatal mice permit influenza-induced persistent pulmonary dysfunction. J Immunol 181:3486-3494. http://dx.doi.org/10.4049/jimmunol.181.5.3486.
70. + T-cell memory. J Virol 74: 11690-11696. http://dx.doi.org/10.1128/JVI.74.24.11690-11696.2000.
71. + T cells is dictated by antigen exposure history and nature of the infection. Immunity 34:781-793. http://dx.doi.org/10.1016/j.immuni.2011.03.020.
72. Masopust D, Ha SJ, Vezys V, Ahmed R. 2006. Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination. J Immunol 177:831-839. http://dx.doi.org/10.4049/jimmunol.177.2.831.
73. + T cells are critical for protection against influenza A virus. Immunity 39:939-948. http://dx.doi.org/10.1016/j.immuni.2013.09.013.
74. + T cell differentiation. Immunity 33:128-140. http://dx.doi.org/10.1016/j.immuni.2010.06.014.
75. La Gruta NL, Kedzierska K, Stambas J, Doherty PC. 2007. A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 85:85-92. http://dx.doi.org/10.1038/sj.icb.7100026.
76. Stary G, Olive A, Radovic-Moreno AF, Gondek D, Alvarez D, Basto PA, Perro M, Vrbanac VD, Tager AM, Shi J, Yethon JA, Farokhzad OC, Langer R, Starnbach MN, von Andrian UH. 2015. Vaccines: a mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells. Science 348:aaa8205. http://dx.doi.org/10.1126/science.aaa8205.
77. Neumann G, Noda T, Kawaoka Y. 2009. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459:931-939. http://dx.doi.org/10.1038/nature08157.